1992 MacArthur Fellows In Science Are Grateful For `Venture Capital'

Since 1981, the Chicago-based John D. and Catherine T. MacArthur Foundation's MacArthur Fellows Program has awarded more than $100 million to nearly 300 individuals in a wide range of professions. The generous, unrestricted awards allow MacArthur fellows the freedom to carry out research and pursue projects they otherwise might never be able to even contemplate. This year, the MacArthur Foundation selected nine scientists among its 33 fellowship recipients. Many of these researchers say the fin

Written byLance Frazer
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Since 1981, the Chicago-based John D. and Catherine T. MacArthur Foundation's MacArthur Fellows Program has awarded more than $100 million to nearly 300 individuals in a wide range of professions. The generous, unrestricted awards allow MacArthur fellows the freedom to carry out research and pursue projects they otherwise might never be able to even contemplate.

This year, the MacArthur Foundation selected nine scientists among its 33 fellowship recipients. Many of these researchers say the financial freedom afforded by the large grants is a tremendous relief. "Funds for the kind of research I do have been extraordinarily scarce," says John Terborgh, James B. Duke Professor of Environmental Science at Duke University and director of the university's Center for Tropical Conservation, who received a $335,000 grant. "Having this award could be [viewed as] the equivalent of driving with the handbrake on, and then suddenly releasing the handbrake. It's that kind of feeling."

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies